Sioux Falls, SD, United States of America

James Viktor Pottala

This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: True Health IP LLC, Integrated Health Leaders, LLC, Sanford Health. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Viktor Pottala. Retrieved from https://idiyas.com/inventor/james-viktor-pottala

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 20.0

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of James Viktor Pottala in Glucose Metabolism**

Introduction

James Viktor Pottala is a prominent inventor based in Sioux Falls, South Dakota. Renowned for his significant contributions to the field of glucose metabolism and cardiovascular health, he holds a total of five patents. His latest inventions focus on advancing methods for predicting and treating abnormal blood glucose levels, showcasing a commitment to improving patient care and clinical outcomes.

Latest Patents

One of his notable inventions is a **Method of determination of risk of 2 hour blood glucose equal to or greater than 140 mg/dL**. This patent revolves around innovative techniques for predicting the likelihood of abnormal glucose tolerance in subjects. By analyzing a combination of three or more biomarkers linked to specific physiological processes, this method provides a quick and accurate assessment of a subject’s glucose tolerance and potential risks of diabetes or cardio-diabetic conditions.

Another significant patent is the **Method of detection and treatment of clinically significant post-prandial hyperglycemia in normoglycemic patients**. This invention addresses the detection of occult pancreatic beta cell dysfunction and the likelihood of developing significant post-prandial hyperglycemia. Utilizing a single fasting baseline biological sample, the method measures the level of alpha-hydroxybutyrate (AHB) and compares it to reference levels to determine a patient's risk, thereby offering an insightful approach to managing glucose-related disorders.

Career Highlights

James has made impactful strides in his career, working with notable organizations such as True Health IP LLC and Sanford Health. His involvement in these companies has allowed him to contribute to advanced research and the development of innovative health solutions, particularly in the realm of glucose management and overall health improvement.

Collaborations

Throughout his professional journey, James Viktor Pottala has collaborated with distinguished colleagues, including Steve Varvel and Rebecca E. Caffrey. These partnerships have facilitated a fruitful exchange of ideas and expertise, further enhancing the quality of his inventions and research initiatives.

Conclusion

James Viktor Pottala stands out as an influential figure in innovation focused on glucose metabolism and its associated health risks. His commitment to developing effective methods for diagnosis and treatment demonstrates his dedication to advancing medical science and enhancing patient outcomes. Through his patented inventions, he continues to impact the healthcare landscape positively, paving the way for future discoveries in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…